@nihilism QBL cannot be involved in MCL in day-to-day... unless...

@nihilism

QBL cannot be involved in MCL in day-to-day... unless MCL informs QBL, there would be nothing to report. At present there is no major shareholding materialised thus term of disclosure have no relevance at present. Thus its not binding on QBL to inform. terms of acquisition are agreed upon, execution is based on MM licence of MCL. That said NY investor who got them to agree to the sign the deal has been issued his shares... only a matter of time that licence comes thru from MCL.

ASX has no issues with acquisition as long as QBL meets the following 3 criteria... ASX only wants MCL is a valid business, MCL & VitaHemp are valid business without doubt of AK. still due diligence is part of process.

When licence does come, either information will be released directly or QBL will issue shares to MCL hitting its with them. Could be even its there, ASX legal opinion is yet to be approved. I don't know and no one does... but facts don't change the whole thing is hinged upon that MM licence. Followed by MCL being listed on ASX as well...